# eye Insights Issue 09: Oculoplastics Disorders ## expand\_more ![eye Insights Oculoplastics Disorders cover](/sites/g/files/omnuum9886/files/styles/hwp_1_1__100x100_scale/public/eye/files/ei9oculoplastics.png?itok=ssrKQ-Id) In this issue of *eye Insights*, we take a close look at two common oculoplastics disorders seen in ophthalmology practice: primary acquired nasolacrimal duct obstruction (PANDO) and orbital inflammatory syndrome (OIS). Inside, you’ll find key information about how PANDO and OIS are diagnosed, treated, and guidance on when to refer a patient. **In this issue:** - [Message from the Editor-in-Chief](/book/message-editor-chief) - [Two Common Oculoplastics Disorders](/book/two-common-oculoplastics-disorders) - [PANDO: Diagnosis, Treatment, and Referral Guidelines](/book/pando-diagnosis-treatment-and-referral-guidelines) - [OIS: Diagnosis, Treatment, and Referral Guidelines](/book/ois-diagnosis-treatment-and-referral-guidelines) *Editor-in-Chief: Joan W. Miller, MD Managing Editor: Matthew F. Gardiner, MD Clinical Advisory Group: Deeba Husain, MD, Ankoor S. Shah, MD, PhD Communications Director: Suzanne Ward Publications Manager: Rosa Rojas Graphic Design: J Sherman Studio Editor: Elizabeth DiVito Contributors: Suzanne Freitag, MD, and Daniel R. Lefebvre, MD, FACS* [Browse all issues > >](/documents/newsletter/eye-insights) | Email: --- Attachments- [ picture\_as\_pdf eye Insights 9.pdf ](/sites/g/files/omnuum9886/files/eye/files/eyeinsights9webversion.pdf) --- See also:- [ eye Insights ](/newsletter/eye-insights)